<i>Retracted</i> : Smad4 gene silencing enhances the chemosensitivity of human lymphoma cells to adriamycin via inhibition of the activation of transforming growth factor β signaling pathway

Qiuhuan Li, Xiaoyu Liu, Chuanli Zhao

Open source

DOI
10.1002/jcb.28772
Published
2019-05-26
Container
Journal of Cellular Biochemistry
Publisher
Wiley
Open access
unknown

Credibility signals

serious concern Score 29/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1002/jcb.28772,
  title = {<i>Retracted</i>
                    : Smad4 gene silencing enhances the chemosensitivity of human lymphoma cells to adriamycin via inhibition of the activation of transforming growth factor β signaling pathway},
  author = {Qiuhuan Li and Xiaoyu Liu and Chuanli Zhao},
  year = {2019},
  journal = {Journal of Cellular Biochemistry},
  doi = {10.1002/jcb.28772},
  url = {https://doi.org/10.1002/jcb.28772}
}

RIS

TY  - JOUR
TI  - <i>Retracted</i>
                    : Smad4 gene silencing enhances the chemosensitivity of human lymphoma cells to adriamycin via inhibition of the activation of transforming growth factor β signaling pathway
AU  - Qiuhuan Li
AU  - Xiaoyu Liu
AU  - Chuanli Zhao
PY  - 2019
JO  - Journal of Cellular Biochemistry
DO  - 10.1002/jcb.28772
UR  - https://doi.org/10.1002/jcb.28772
ER  - 

APA

Li, Q., Liu, X., & Zhao, C. (2019). <i>Retracted</i> : Smad4 gene silencing enhances the chemosensitivity of human lymphoma cells to adriamycin via inhibition of the activation of transforming growth factor β signaling pathway. Journal of Cellular Biochemistry. https://doi.org/10.1002/jcb.28772

Source records